1. Home
  2. Buyout

Category: cell

Welsh Carson commits up to $250m to newly-formed cell, gene science investor Kiniciti

Private equity major Welsh, Carson, Anderson & Stowe has agreed to commit up to $250m to a strategic partnership with newly-formed Kiniciti, to invest in non-therapeutic companies supporting cell and gene therapy innovation.

BGF backs human cell disease model startup DefiniGEN

UK investment house BGF has backed a £3.25m funding round for DefiniGEN, a provider of human cell products and services.